HCM
NVLN

Highbridge Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Highbridge Capital Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-581,042
Closed -$421K – 107
2019
Q3 		$421K Sell
581,042
-337,300
-37% -$244K 0.09% 62
2019
Q2 		$716K Sell
918,342
-28,500
-3% -$31.7K 0.07% 118
2019
Q1 		$1.17M Hold
946,842
– – 0.05% 264
2018
Q4 		$795K Buy
+946,842
New +$1.07M 0.04% 277
2017
Q4 		– Sell
-858,144
Closed -$6.03M – 2448
2017
Q3 		$6.03M Sell
858,144
-298,462
-26% -$2.39M 0.14% 257
2017
Q2 		$10.7M Buy
1,156,606
+531,338
+85% +$5.12M 0.23% 161
2017
Q1 		$6.72M Buy
+625,268
New +$6.39M 0.13% 261
2016
Q4 		– Hold
0
– – – 1844

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return